More transparency, accountability and inclusion needed in ACT-A – Letter to ACT-A Leadership and Brief from CS and Community Representatives
On Monday February 22nd 2021, the Platform sent to the major actors within ACT-A a letter providing details about the changes civil society and communities are asking for in order to increase transparency and accountability in decision-making to ensure the ACT-A is more inclusive going forward. We have called for a new culture of transparency throughout the structure so that if the ACT-A is to be legitimate, accountable and ultimately effective there needs to be a drastic improvement to the depth of engagement with civil society, communities and delegations from LMICs. We have asked for full transparency in contracts negotiated with pharmaceutical companies or research institutions, a detailed map of the current decision-making pathways, governance oversight and processes of consultation from priority setting, resource allocation through to procurement and deployment. We’ve requested civil society and community seats at the “real” decision-making tables. In its first year, ACT-A has been successful in many ways – for it to really drive and achieve its underlying equity mandate, its time to be more clear, more transparent and more inclusive.
Links to resources on COVID-19, ACT-A, Calls to Action, and other tools.
- FIND: COVID-19 DIAGNOSTICS & TESTING
- Access to COVID-19 Tools (ACT) Accelerator Diagnostics Partnership
Health Systems Connector
- WHO: Access to COVID-19 Tools (ACT) Accelerator
- WHO: ACT-Accelerator update
- UNITAID: ACT-Accelerator Investment Case
- The Global Fund: Access to COVID-19 Tools Accelerator
- COVID Advocates Advisory Board (CAAB)
Live from the First COVID-19 ACT-Accelerator Facilitation Council meeting with Tedros Adhanom GhebreyesusPosted by World Health Organization (WHO) on Thursday, 10 September 2020
The First COVID-19 ACT-Accelerator Facilitation Council meeting with Dr. Tedros Adhanom Ghebreyesus.